Results 131 to 140 of about 2,604,284 (151)

Near Infrared Photoimmunotherapy for Locoregionally Recurrent Oropharyngeal Squamous Cell Carcinoma at Tongue Base After Chemoradiotherapy: A Case Report and Literature Review. [PDF]

Cureus
Tamagawa S, Okuda K, Nishikawa D, Kono M, Hotomi M.   +4 more
europepmc   +1 more source

Near-Infrared Photoimmunotherapy Using a Protein Mimetic for EGFR-Positive Salivary Gland Cancer. [PDF]

Int J Mol Sci
Yamaguchi H, Suzuki T, Okada Y, Ono J, Sano H, Banba A, Sakata H, Ishikawa A, Morita T.   +8 more
europepmc   +1 more source

Near-infrared photoimmunotherapy targeting Nectin-4 in a preclinical model of bladder cancer. [PDF]

Cancer Lett
Fukushima H, Takao S, Furusawa A, Valera Romero V, Gurram S, Kato T, Okuyama S, Kano M, Choyke PL, Kobayashi H.   +9 more
europepmc   +1 more source

Changes in serum DAMPs and cytokines/chemokines during near-infrared photoimmunotherapy for patients with head and neck cancer. [PDF]

Cancer Med
Ishihara H, Nishikawa D, Muraoka D, Masago K, Beppu S, Terada H, Matsushita H, Hanai N.   +7 more
europepmc   +1 more source

Near infrared spectroscopy analysis of essential oils - Can statistical correlation to mid infrared and Raman spectra assist the interpretation?

, 2005
Schulz, Hartwig, Baranska, Malgorzata, Quilitzsch, Rolf   +2 more
core  

Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers

Cancers, 2022
SIMPLE SUMMARY: Near-infrared photoimmunotherapy (NIR-PIT) is a novel molecularly-targeted therapy that induces rapid cancer cell death by systemically administering an antibody-photoabsorber conjugate (APC) that binds to cancer cells and irradiating NIR
Peter A Pinto, Aki Furusawa, Baris Turkbey   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

PD-L1 near Infrared Photoimmunotherapy of Ovarian Cancer Model

Cancers, 2022
Balaji Krishnamachary, Chien-Fu Hung, James D Barnett   +2 more
exaly  

Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy

Cancers, 2021
Hiroaki Wakiyama, Aki Furusawa, Hisataka Kobayashi   +2 more
exaly  

Eligibility for Photoimmunotherapy in Patients with Unresectable Advanced or Recurrent Head and Neck Cancer and Changes before and after Systemic Therapy

Cancers, 2023
Takeshi Shinozaki, Kazuto Matsuura, Toshifumi Tomioka   +2 more
exaly